# Advanced Targeted Drug Delivery for Colon Cancer Using Pristine and Surface-modified Hydroxyapatite Nanoparticles: Synthesis, Characterization, and pH-Responsive Release

Source: [Advanced Targeted Drug Delivery for Colon Cancer Using Pristine and Surface-modified Hydroxyapatite Nanoparticles: Synthesis, Characterization, and pH-Responsive Release](<https://www.sota2.com/research/paper/68fa5f601e209131ce9e96cc>)

Collection index: [llms.txt](<https://www.sota2.com/research/llms.txt>)

Data updated: 2025-10-25T19:15:45.160Z

Authors: Alexander David McGuire Withrow, Sean M Blythe, Jack Thomas Burton, Camryn Grace Evett

Published: 2024-09-26T18:04:29.000Z

## Abstract

Hydroxyapatite nanoparticles (HANs) have emerged as a promising candidate for targeted drug delivery in the treatment of colon cancer, a disease that remains one of the leading causes of cancer-related deaths globally. In this study, we synthesized and characterized HANs for their potential use as drug delivery vehicle for anticancer drugs specifically targeting colon cancer treatment. Through various in vitro assays, including drug loading efficiency, release kinetics, we demonstrated that HANs exhibit efficient drug loading capacity, and sustained release behavior, which could collectively contribute to enhanced therapeutic outcomes against colon cancer cells. The findings highlight the potential of HANs to serve as a versatile platform for the targeted drug delivery of chemotherapeutic agents, offering a novel approach that could improve treatment efficacy while minimizing side effects due to biocompatibility of the particles. Future research should focus on in vivo studies and clinical translation to further validate the potential of HANs in cancer therapy as drug carrier.

## Recorded benchmark results

A research result applies to its stated dataset, split, metric and evaluation configuration. Compare like-for-like settings, preserve the metric's unit and direction, and distinguish paper-reported results from independent reproduction. The best result recorded here is not a claim of exhaustive, current global coverage.

## Original sources and implementation

[Original paper](<https://arxiv.org/abs/2409.18192>)

[PDF](<https://arxiv.org/pdf/2409.18192.pdf>)
